Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin

Drug Delivery

Volumn 14, Issue 6, 2007, Pages 371-380

  Gryparis, E C ^a   Mattheolabakis, G ^a   Bikiaris, D ^b   Avgoustakis, K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cisplatin Encapsulation; Double Emulsion Method; PLGA PEG; Poly(Lactide Co Glycolide) Methoxy Poly(Ethylene Glycol) Nanoparticles; Preparation Conditions

Indexed keywords

CISPLATIN; COPOLYMER; GLUCOSE; GLUTAMIC ACID; LACTOSE; MACROGOL; MANNITOL; N,N DIMETHYLFORMAMIDE; NANOPARTICLE; TREHALOSE;

ARTICLE; DRUG FORMULATION; ENCAPSULATION; FREEZE DRYING; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; ULTRASOUND;

ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG CARRIERS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLACTIN 910;

EID: 34547959226     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540701202937     Document Type: Article

References (19)

1. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Karydas, A. G., and Ithakissios, D. S. 2002. PLGA-mPEGnanoparticles of cisplatin: in vitro nanoparticle degradation in vitro drug release in vivo drug residence in blood properties. J. Control. Rel. 79:123-135.
2. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Livaniou, E., Evangelatos, G., and Ithakissios, D. S. 2003. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int. J. Pharm. 259:115-127.
3. Avichezer, D., Schechter, B., and Arnon, R. 1998. Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates - effect on human ovarian carcinoma. Reactive & Functional Polymers 36:59-69.
4. Beletsi, A., Leondiadis, L., Klepetsanis, P., Ithakissios, D. S., and Avgoustakis, K. 1999. Effect of preparative variables on the properties of PLGA-mPEG copolymers related to their application in controlled drug delivery. Int J Pharm. 182:187-197.
5. Bilati, U., Allemann, E., and Doelker, E. 2005. Poly(D,L-lactide-co- glycolide) protein loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency. J. Microencapsul. 22:205-214.
6. De Jaeghere, F., Allemann, E., Leroux, J. C., Stevels, W., Feijen, J., Doelker, E., and Gurny, R. 1999. Formulation and lyoprotection of poly(lactic acidco-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res. 16:859-866.
7. Egea, M. A, Gamisans, F., Valero, J., Garcia, M. E., and Garcia, M. L. 1994. Entrapment of cisplatin into biodegradable polyalkylcyanocrylate nanoparticles. Farmaco 49:211-217.
8. Ferruti, P., Ranucci, E., Trotta, F., Gianasi, E., Evagorou, E. G., Wasil, M., Wilson, G., and Duncan, R. 1999. Synthesis, characterization and antitumor activity of platinum II complexes of novel functionalised poly(amidoamine)s. Macromol. Chem. Phys. 200:1644-1654.
9. Gianasi, E., Wasil, M., Evagorou, E. G., Keddle, A., Wilson, G., and Duncan, R. 1999. HPMA copolymer platinates as novel antitumor agents: in vitro properties, pharmacokinetics and antitumor activity in vivo. Eur. J. Cancer 35:994-1002.
10. Gorner, T., Gref, R., Michenot, D., Sommer, F., Tran, M. N., and Dellacherie, E. 1999. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J. Control. Rel. 57:259-268.
11. Kwon, G. S. 1998. Diblock copolymer nanoparticles for drug delivery. CRC Crit. Rev. Ther. Drug Carrier Syst. 15:481-512.
12. Lamprecht, A., Ubrich, N., Hombreiro, P. M., Lehr, C. M., Hoffman, M., and Maincent, P. 2000. Influence of process parameters on nanoparticle preparation by a double emulsion pressure homogenization technique. Int. J. Pharm. 196:177-182.
13. Li, X., Deng, X., Yuan, M., Xiong, C., Huang, Z., Zhang, Y., and Jia, W. 1999. Investigation on process parameters involved in preparation of poly-DL-lactidepoly(ethylene glycol) microspheres containing Leptospira Interrogans antigens. Int. J. Pharm. 178:245-255.
14. Malik, N., Evagorou, E. G., and Duncan, R. 1999. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10:767-776.
15. Newman, M. S., Golbern, G. T., Working, P. K., Engbers, C., and Amantea, M. A. 1999. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother. Pharmacol. 43:1-7.
16. Nishiyama, N., Kato, Y., Sugiyama, Y., and Kataoka, K. 2001. Cisplatin-loaded polymer-metal complex micelle with time modulated decaying property as a novel drug delivery system. Pharm. Res. 18:1035-1041.
17. Ogawa, Y., Yamamoto, M., Okada, H., Yashiki, T., and Shimamoto, T. 1988. A new technique to efficiently entrap leuprolide acetate in microcapsules of copoly(lactic/glycolic acid). Chem. Pharm. Bull. 36:1095-1103.
18. Sedletska, Y., Giraud-Panis, M. J., and Malinge, J. M. 2005. Cisplatin is a DNA-damaging antitumour compound triggering multifunctional biochemical responses in cancer cells: importance of apoptotic pathways. Curr. Med. Chem. Anticancer Agents 5:251-265.
19. Xu, P., Van Kirk, E. A., Li, S., Murdoch, W. J., Ren, J., Hussain, M. D., Radosz, M., and Shen, Y. 2006. Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloids Surf B: Biointerfac 48:50-57.